Why Alnylam Pharmaceuticals Stock Slipped Today
The Motley Fool
by newsfeedback@fool.com (Eric Volkman)February 13, 2026
The company's Amvuttra is proving to be quite the motor of growth these days.
Verticals
financeinvesting
Originally published on The Motley Fool on 2/13/2026